CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates chronic pain mechanisms to develop personalized treatments. By analyzing biomarkers and glial activation in patients, the project aims to improve analgesic efficacy while minimizing adverse effects, focusing on conditions like fibromyalgia and arthritis.
Chronic pain is prevalent and it causes decreased quality of life and significant costs to the society in terms of lost working capacity.
Currently available analgesics are either not effective enough or patients cannot take them due to adverse effects.
Non-steroidal anti-inflammatory drugs are a major cause of drug-related morbidity and mortality.
Opioids can cause tolerance and addiction when used for long-term management of chronic pain.
Analgesic efficacy can be improved by targeting specifi…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, Stockholm
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Frankfurt Am Main
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Illkirch Graffenstaden
Type: Research institute
Activity type: Research Organisations
SME: No
Estonia, TARTU
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
